Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	78
Overall Study	STARTED	Losartan 10 mg	80
Overall Study	STARTED	Losartan 25 mg	82
Overall Study	STARTED	Losartan 50 mg	79
Overall Study	STARTED	Losartan 100 mg	90
Overall Study	STARTED	Losartan 150 mg	84
Overall Study	STARTED	Enalapril 20	83
Overall Study	COMPLETED	Placebo	67
Overall Study	COMPLETED	Losartan 10 mg	72
Overall Study	COMPLETED	Losartan 25 mg	75
Overall Study	COMPLETED	Losartan 50 mg	76
Overall Study	COMPLETED	Losartan 100 mg	80
Overall Study	COMPLETED	Losartan 150 mg	77
Overall Study	COMPLETED	Enalapril 20	79
Overall Study	NOT COMPLETED	Placebo	11
Overall Study	NOT COMPLETED	Losartan 10 mg	8
Overall Study	NOT COMPLETED	Losartan 25 mg	7
Overall Study	NOT COMPLETED	Losartan 50 mg	3
Overall Study	NOT COMPLETED	Losartan 100 mg	10
Overall Study	NOT COMPLETED	Losartan 150 mg	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00882440/flow